Article ID Journal Published Year Pages File Type
8316993 Clinical Biochemistry 2018 30 Pages PDF
Abstract
Our data suggests PKM2 as a putative biomarker for IBD and the dysbiosis of microflora in CD. Investigations involving larger number of clinical patients are necessary to validate its use as a serum biomarker of IBD.
Keywords
Related Topics
Life Sciences Biochemistry, Genetics and Molecular Biology Biochemistry
Preview
Elevation of serum pyruvate kinase M2 (PKM2) in IBD and its relationship to IBD indices
Authors
, , , , ,